Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03116737 · ClinicalTrials.gov registry record · Phase 3
Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children
A Phase 3 study of Pain and Acute Otitis Media, sponsored by Lachlan Pharma Holdings.
- Completed
- Registry status
- Phase 3
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT03116737 is a Phase 3 study of Pain and Acute Otitis Media that has completed, run by Lachlan Pharma Holdings. The registered enrollment target is 141 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03116737, a Phase 3 study of Pain and Acute Otitis Media, has completed, sponsored by Lachlan Pharma Holdings.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
The Phase III study is designed to assess the safety, tolerability, and efficacy of Topical Benzocaine in children, ages 5 to 12 years, presenting with Acute Otitis Media-associated ear pain.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Benzocaine Otic Solution
Study Locations (1)
Oregon
- Cyn3rgy Research - Gresham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2017-01-03 |
| Est. Completion | 2017-07-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03116737
The ClinicalTrials.gov registry entry for NCT03116737 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (54% lower). The listed sponsor is Lachlan Pharma Holdings, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03116737 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03116737 about?
NCT03116737 is a clinical study titled "Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children". The Phase III study is designed to assess the safety, tolerability, and efficacy of Topical Benzocaine in children, ages 5 to 12 years, presenting with Acute Otitis Media-associated ear pain.
What is the current status of trial NCT03116737?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 141 participants. The study started on 2017-01-03. Estimated completion is 2017-07-21.
What conditions does trial NCT03116737 study?
This clinical trial studies the following conditions: Pain, Acute Otitis Media.
What interventions are being tested in trial NCT03116737?
The interventions under investigation include: Placebo (DRUG), Benzocaine Otic Solution (DRUG).
Who is sponsoring clinical trial NCT03116737?
This trial is sponsored by Lachlan Pharma Holdings, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03116737 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.